patients with chronic P aeruginosa lung infection have been treated every third month with intravenous antipseudomonal chemotherapy for two weeks.'" The mean age of patients acquiring chronic P aeruginosa infection was 9-7 years during the study period.2
CLASSIFICATION OF P AERUGINOSA INFECTION
Since 1972 all patients have been examined at least once a year for serum precipitating antibodies to P aeruginosa.' The patients were said to be intermittently colonised when P aeruginosa was harboured in the respiratory tract for less than six months and there were less than two precipitins, and to have chronic P aeruginosa infection when bacteria were cultured continuously from sputum for six months or there was an antibody response of two precipitins or more." These definitions have remained unchanged during the study period.
Case reports were scrutinised for all 300 patients followed in the Danish cystic fibrosis centre from 1 January 1965 to 31 December 1990 and the above definitions were applied to the data. Day, month, and year were recorded for (1) initial colonisation-that is, the date of the first sputum sample to be positive for P aeruginosa (these patients being designated as intermittently colonised until they fulfilled the criteria for chronic infection); and (2) day, month, and year of onset of chronic P aeruginosa infection-that is, of continuous culture of P aeruginosa from sputum for six months or an antibody response of two precipitins or more.
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ANALYSIS
Results are expressed as percentage values, with 99% confidence intervals (CI) and significance assessed by x2 test for categorical data. 12 Results During the study period 239 patients had intermittent P aeruginosa colonisation and 182 acquired chronic infection; all had been intermittently colonised previously.
The seasonal distribution of initial colonisation during the successive periods of the study is shown in table 1. Sixty six per cent (99% CI 57-74%) of the initial colonisation took place during the winter months. No significant fluctuations were seen over the 26 years of the study (p = 0-75). The number of patients who acquired the initial colonisation each month over the entire study period is shown in figure 1. The lowest incidence was in July and the highest incidence in October. infections was not convincingly higher in patients with cystic fibrosis than in healthy controls but that the consequences of the infections were more serious, which is also in agreement with the findings of Deforest et al. 8 Fewer stable patients showed serological evidence of non-bacterial infections than the unstable patients. Brocklebank et al '9 found that the interaction between respiratory virus infection and chronic respiratory diseases such as cystic fibrosis has become increasingly important for the health of these children as they are more likely to acquire severe lower The elimination of cross infection in the centre, by improvement of hygiene and the separation of infected and non-infected patients since 1980, may also be a factor. These changes, however, do not explain why the seasonal onset of P aeruginosa has not changed over the 26 years. The most likely explanation seems to be that respiratory virus infections pave the way for P aeruginosa colonisation and chronic infection in patients with cystic fibrosis.
Like other authors, 342223 we suggest that prophylactic procedures such as vaccination against respiratory viruses and intensive surveillance and treatment of patients with cystic fibrosis who have confirmed respiratory virus infections may be a way to decrease the high incidence of P aeruginosa colonisation and infection during the winter. Such measures may improve further the prognosis in cystic fibrosis. 
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